The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?

Epithelial‐to‐mesenchymal transition (EMT) is a fundamental process in development and disease. Zinc‐finger enhancer binding (ZEB) transcription factors (ZEB1 and ZEB2) are crucial EMT activators, whereas members of the miR‐200 family induce epithelial differentiation. They are reciprocally linked in a feedback loop, each strictly controlling the expression of the other. Now data show that EMT not only confers cellular motility, but also induces stem‐cell properties and prevents apoptosis and senescence. Thus the balanced expression of ZEB factors and miR‐200 controls all these processes. We therefore propose that the ZEB/miR‐200 feedback loop is the molecular motor of cellular plasticity in development and disease, and in particular is a driving force for cancer progression towards metastasis by controlling the state of cancer stem cells.

[1]  J. Nesland,et al.  Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma , 2005, Cancer.

[2]  J. Zhang,et al.  miR-200bc/429 cluster targets PLCγ1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer , 2010, Oncogene.

[3]  Patricia Greninger,et al.  A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. , 2009, Cancer cell.

[4]  A. Osunkoya,et al.  Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells , 2009, Breast Cancer Research and Treatment.

[5]  Meenakshi Singh,et al.  ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease , 2008, Modern Pathology.

[6]  Sun-Mi Park,et al.  miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. , 2010, Molecular cell.

[7]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[8]  A. Osunkoya,et al.  Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. , 2008, Cancer research.

[9]  W. L. Ruzzo,et al.  MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries , 2008, Stem cells.

[10]  B. Davidson,et al.  Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions , 2010, Clinical & Experimental Metastasis.

[11]  T. Brabletz,et al.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.

[12]  D. McConkey,et al.  Delta-Crystallin Enhancer Binding Factor 1 Controls the Epithelial to Mesenchymal Transition Phenotype and Resistance to the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Human Head and Neck Squamous Cell Carcinoma Lines , 2009, Clinical Cancer Research.

[13]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[14]  Woonyoung Choi,et al.  miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy , 2009, Clinical Cancer Research.

[15]  Marina Kriajevska,et al.  SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer , 2009, Proceedings of the National Academy of Sciences.

[16]  Jae Hoon Kim,et al.  MicroRNA Expression Profiles in Serous Ovarian Carcinoma , 2008, Clinical Cancer Research.

[17]  I. Fabregat,et al.  Snail blocks the cell cycle and confers resistance to cell death. , 2004, Genes & development.

[18]  Birgit Luber,et al.  Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. , 2002, The American journal of pathology.

[19]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[20]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[21]  M. Nieto,et al.  Inflammation and EMT: an alliance towards organ fibrosis and cancer progression , 2009, EMBO molecular medicine.

[22]  T. Gress,et al.  Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer , 2007, Oncogene.

[23]  E. Howe,et al.  Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers , 2009, Journal of oncology.

[24]  I. Pogribny,et al.  E‐cadherin transcriptional down‐regulation by epigenetic and microRNA‐200 family alterations is related to mesenchymal and drug‐resistant phenotypes in human breast cancer cells , 2010, International journal of cancer.

[25]  R. Cameron,et al.  Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. , 2006, Cancer research.

[26]  Tatyana Chernova,et al.  Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. , 2007, Molecular biology of the cell.

[27]  E. Hurt,et al.  Expression of the ZEB1 (δEF1) transcription factor in human: additional insights , 2008, Molecular and Cellular Biochemistry.

[28]  G. Browne,et al.  ZEB proteins link cell motility with cell cycle control and cell survival in cancer , 2010, Cell cycle.

[29]  L. Buscail,et al.  MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. , 2010, Clinical chemistry.

[30]  V. Kim,et al.  Conserved MicroRNA miR-8/miR-200 and Its Target USH/FOG2 Control Growth by Regulating PI3K , 2009, Cell.

[31]  O. Kent,et al.  A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells , 2009, Cancer biology & therapy.

[32]  S. Elledge,et al.  Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase , 2003, Cell.

[33]  M. Peter.  Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression , 2009, Cell cycle.

[34]  Zhihui Feng,et al.  A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. , 2009, Gynecologic oncology.

[35]  R. Maestro,et al.  Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. , 2008, Cancer cell.

[36]  G. Gallick,et al.  Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells , 2007, Annals of Surgical Oncology.

[37]  Cameron P Bracken,et al.  MicroRNAs as regulators of epithelial-mesenchymal transition , 2008, Cell cycle.

[38]  Zhiwei Wang,et al.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. , 2009, Cancer research.

[39]  Huamin Wang,et al.  Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. , 2009, Cancer research.

[40]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[41]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[42]  Laura Pelletier,et al.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.

[43]  Kevin Struhl,et al.  MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells , 2009, Science Signaling.

[44]  Jun Du,et al.  BMP-6 inhibits microRNA-21 expression in breast cancer through repressing δEF1 and AP-1 , 2009, Cell Research.

[45]  R. Foisner,et al.  The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity , 2007, Oncogene.

[46]  A. Postigo,et al.  ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1 , 2010, Oncogene.

[47]  T. Sjöblom,et al.  Sustained TGFβ exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis , 2007, Oncogene.

[48]  Wen-juan Wang,et al.  Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells , 2009, Clinical Cancer Research.

[49]  K. Horwitz,et al.  The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. , 2006, Cancer research.

[50]  E. Bellefroid,et al.  δEF1 and SIP1 are differentially expressed and have overlapping activities during Xenopus embryogenesis , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[51]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[52]  G. Berx,et al.  The role of the ZEB family of transcription factors in development and disease , 2009, Cellular and Molecular Life Sciences.

[53]  R. Knuechel,et al.  Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Douglas S. Darling,et al.  Zeb1 links epithelial-mesenchymal transition and cellular senescence , 2008, Development.

[55]  J. Lieberman,et al.  miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases , 2009, PloS one.

[56]  M. Herlyn,et al.  Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. , 2010, Cancer research.

[57]  H. Zhang,et al.  MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. , 2009, Genes & development.

[58]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[59]  M. Zhou,et al.  microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. , 2010, Carcinogenesis.

[60]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[61]  M. F. Shannon,et al.  A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. , 2008, Cancer research.

[62]  K. Sossey-Alaoui,et al.  The miR200 Family of MicroRNAs Regulates WAVE3-dependent Cancer Cell Invasion* , 2009, The Journal of Biological Chemistry.

[63]  Alexander Pertsemlidis,et al.  Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. , 2009, Genes & development.

[64]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[65]  I. Gérin,et al.  The microRNA miR-8 is a conserved negative regulator of Wnt signaling , 2008, Proceedings of the National Academy of Sciences.

[66]  S. Spivack,et al.  Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. , 2007, Cancer research.

[67]  Asli Silahtaroglu,et al.  miR-200b mediates post-transcriptional repression of ZFHX1B. , 2007, RNA.

[68]  J. Haley,et al.  Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition , 2007, Molecular Cancer Therapeutics.

[69]  R. Figlin,et al.  Tumor Response to Combination Celecoxib and Erlotinib Therapy in Non-small Cell Lung Cancer Is Associated with a Low Baseline Matrix Metalloproteinase-9 and a Decline in Serum-Soluble E-Cadherin , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[70]  T. Sjöblom,et al.  Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. , 2008, Oncogene.

[71]  J. Minna,et al.  Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. , 2006, Cancer research.

[72]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[73]  Yoshihiro Adachi,et al.  Zeb1‐mediated T‐cadherin repression increases the invasive potential of gallbladder cancer , 2009, FEBS letters.

[74]  B. Karlan,et al.  Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. , 2010, Gynecologic oncology.

[75]  Thomas Kirchner,et al.  Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.

[76]  A. Postigo,et al.  Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins , 2003, The EMBO journal.

[77]  G. Berx,et al.  A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. , 2006, Gastroenterology.

[78]  G. Niedobitek,et al.  The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. , 2001, The American journal of pathology.

[79]  Thomas Kirchner,et al.  Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and β-Catenin , 2005, Cells Tissues Organs.

[80]  Zhiwei Wang,et al.  Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. , 2009, Cancer research.

[81]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[82]  X. Bian,et al.  miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. , 2010, Biochemical and biophysical research communications.

[83]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[84]  A. Dimmler,et al.  The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. , 2008, Cancer research.

[85]  M. Korpal,et al.  The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.